132 related articles for article (PubMed ID: 37802571)
1. 17β-Hydroxysteroid dehydrogenases types 1 and 2: Enzymatic assays based on radiometric and mass-spectrometric detection.
Sinreih M; Gjorgoska M; Möller G; Adamski J; Rižner TL
Methods Enzymol; 2023; 689():201-234. PubMed ID: 37802571
[TBL] [Abstract][Full Text] [Related]
2. High mRNA levels of 17β-hydroxysteroid dehydrogenase type 1 correlate with poor prognosis in endometrial cancer.
Cornel KM; Krakstad C; Delvoux B; Xanthoulea S; Jori B; Bongers MY; Konings GF; Kooreman LF; Kruitwagen RF; Salvesen HB; ; Romano A
Mol Cell Endocrinol; 2017 Feb; 442():51-57. PubMed ID: 27923582
[TBL] [Abstract][Full Text] [Related]
3. Estrogen and androgen-converting enzymes 17β-hydroxysteroid dehydrogenase and their involvement in cancer: with a special focus on 17β-hydroxysteroid dehydrogenase type 1, 2, and breast cancer.
Hilborn E; Stål O; Jansson A
Oncotarget; 2017 May; 8(18):30552-30562. PubMed ID: 28430630
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of 17β-hydroxysteroid dehydrogenase type 1 increases the exposure of endometrial cancer to 17β-estradiol.
Cornel KM; Kruitwagen RF; Delvoux B; Visconti L; Van de Vijver KK; Day JM; Van Gorp T; Hermans RJ; Dunselman GA; Romano A
J Clin Endocrinol Metab; 2012 Apr; 97(4):E591-601. PubMed ID: 22362820
[TBL] [Abstract][Full Text] [Related]
5. Inhibitors of 17beta-hydroxysteroid dehydrogenase type 1.
Brozic P; Lanisnik Risner T; Gobec S
Curr Med Chem; 2008; 15(2):137-50. PubMed ID: 18220769
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of steroidogenic enzymes according to endometriosis type.
Colette S; Defrère S; Van Kerk O; Van Langendonckt A; Dolmans MM; Donnez J
Fertil Steril; 2013 Dec; 100(6):1642-9. PubMed ID: 24012197
[TBL] [Abstract][Full Text] [Related]
7. Expression of 17beta-hydroxysteroid dehydrogenases and other estrogen-metabolizing enzymes in different cancer cell lines.
Smuc T; Rizner TL
Chem Biol Interact; 2009 Mar; 178(1-3):228-33. PubMed ID: 19022235
[TBL] [Abstract][Full Text] [Related]
8. HSD17B1 expression enhances estrogen signaling stimulated by the low active estrone, evidenced by an estrogen responsive element-driven reporter gene in vivo.
Järvensivu P; Saloniemi-Heinonen T; Awosanya M; Koskimies P; Saarinen N; Poutanen M
Chem Biol Interact; 2015 Jun; 234():126-34. PubMed ID: 25617485
[TBL] [Abstract][Full Text] [Related]
9. One 3-oxoacyl-(acyl-Carrier-protein) reductase functions as 17β-hydroxysteroid dehydrogenase in the estrogen-degrading Pseudomonas putida SJTE-1.
Wang P; Zheng D; Wang Y; Liang R
Biochem Biophys Res Commun; 2018 Nov; 505(3):910-916. PubMed ID: 30309659
[TBL] [Abstract][Full Text] [Related]
10. Characterization of 17β-hydroxysteroid dehydrogenase and regulators involved in estrogen degradation in Pseudomonas putida SJTE-1.
Wang P; Zheng D; Peng W; Wang Y; Wang X; Xiong W; Liang R
Appl Microbiol Biotechnol; 2019 Mar; 103(5):2413-2425. PubMed ID: 30623203
[TBL] [Abstract][Full Text] [Related]
11. Novel hydroxysteroid (17beta) dehydrogenase 1 inhibitors reverse estrogen-induced endometrial hyperplasia in transgenic mice.
Saloniemi T; Järvensivu P; Koskimies P; Jokela H; Lamminen T; Ghaem-Maghami S; Dina R; Damdimopoulou P; Mäkelä S; Perheentupa A; Kujari H; Brosens J; Poutanen M
Am J Pathol; 2010 Mar; 176(3):1443-51. PubMed ID: 20093485
[TBL] [Abstract][Full Text] [Related]
12. New development in intracrinology of breast carcinoma.
Sasano H; Suzuki T; Nakata T; Moriya T
Breast Cancer; 2006; 13(2):129-36. PubMed ID: 16755106
[TBL] [Abstract][Full Text] [Related]
13. The regulation of hydroxysteroid 17β-dehydrogenase type 1 and 2 gene expression in breast cancer cell lines by estradiol, dihydrotestosterone, microRNAs, and genes related to breast cancer.
Hilborn E; Stål O; Alexeyenko A; Jansson A
Oncotarget; 2017 Sep; 8(37):62183-62194. PubMed ID: 28977936
[TBL] [Abstract][Full Text] [Related]
14. Estrone/17beta-estradiol conversion to, and tumor necrosis factor inhibition by, estrogen metabolites in synovial cells of patients with rheumatoid arthritis and patients with osteoarthritis.
Schmidt M; Hartung R; Capellino S; Cutolo M; Pfeifer-Leeg A; Straub RH
Arthritis Rheum; 2009 Oct; 60(10):2913-22. PubMed ID: 19790073
[TBL] [Abstract][Full Text] [Related]
15. The contribution of 17beta-hydroxysteroid dehydrogenase type 1 to the estradiol-estrone ratio in estrogen-sensitive breast cancer cells.
Zhang CY; Chen J; Yin DC; Lin SX
PLoS One; 2012; 7(1):e29835. PubMed ID: 22253796
[TBL] [Abstract][Full Text] [Related]
16. Expression of 17β-hydroxysteroid dehydrogenase type 1 in gastric cancer.
Frycz BA; Murawa D; Wysocki-Borejsza M; Marciniak R; Murawa P; Drews M; Jagodziński PP
Biomed Pharmacother; 2013 Sep; 67(7):651-7. PubMed ID: 23916544
[TBL] [Abstract][Full Text] [Related]
17. Conversion of Estrone to 17β-Estradiol: A Potential Confounding Factor in Assessing Risks of Environmental Estrogens to Fish.
Tapper MA; Kolanczyk RC; LaLone CA; Denny JS; Ankley GT
Environ Toxicol Chem; 2020 Oct; 39(10):2028-2040. PubMed ID: 33448467
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of Human Estrogen Biosynthetic Enzyme Hydroxysteroid (17beta) Dehydrogenase Type 1 Induces Adenomyosis-like Phenotype in Transgenic Mice.
Heinosalo T; Rytkönen KT; Saarinen N; Järvensivu P; Damdimopoulou P; Strauss L; Orasniemi S; Horshauge P; Gabriel M; Koskimies P; Ohlsson C; Kronqvist P; Poutanen M
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563206
[TBL] [Abstract][Full Text] [Related]
19. Retinoic acid (RA) regulates 17beta-hydroxysteroid dehydrogenase type 2 expression in endometrium: interaction of RA receptors with specificity protein (SP) 1/SP3 for estradiol metabolism.
Cheng YH; Yin P; Xue Q; Yilmaz B; Dawson MI; Bulun SE
J Clin Endocrinol Metab; 2008 May; 93(5):1915-23. PubMed ID: 18270252
[TBL] [Abstract][Full Text] [Related]
20. Relationship between estrogen receptors, 17 beta-hydroxysteroid dehydrogenase and estrogen content in human breast cancer.
Abul-Hajj YJ
Steroids; 1979 Aug; 34(2):217-25. PubMed ID: 494363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
